Kidney Disease Care for Seniors

Chronic kidney disease is largely silent until CKD G4 (eGFR < 30). Early CKD (G1–G3) typically has no symptoms — it is detected only by blood tests (serum creatinine, eGFR calculation) and urine tests (uACR — urine albumin-to-creatinine ratio). Symptoms that can appear in moderate-to-advanced CKD: fatigue and decreased energy (from anemia); swelling in ankles, feet, or around the eyes (from fluid retention); decreased urine output or dark/foamy urine (protein in urine); itching (prurigo in uremia); nausea, decreased appetite, metallic taste in mouth; difficulty concentrating and cognitive changes; muscle cramps, especially at night; shortness of breath (from fluid overload or anemia); and high blood pressure that is difficult to control. In seniors, many of these symptoms are attributed to aging or other conditions — CKD is frequently missed until an incidental blood test reveals elevated creatinine. Annual creatinine and eGFR testing is recommended for all seniors with hypertension or diabetes.

There is no single eGFR threshold that automatically triggers dialysis. The 2012 KDIGO guidelines recommend initiating dialysis based on symptoms, not eGFR alone. Dialysis is typically initiated at eGFR 5–10 mL/min/1.73m² when uremic symptoms are present: intractable fluid overload, uremic encephalopathy, pericarditis, nausea and vomiting causing malnutrition, or severe electrolyte abnormalities unresponsive to medical management. Some patients — particularly elderly patients with multiple comorbidities — choose conservative management (non-dialytic supportive care) at ESRD. Studies show that elderly patients with severe comorbidities (diabetes, heart failure, peripheral vascular disease) may have no survival benefit from dialysis compared to conservative management, while spending a significant portion of their remaining life in dialysis centers. Conservative management with nephrology and palliative care oversight is a valid and evidence-based choice that should be explicitly offered and discussed.

True CKD (sustained eGFR decline for ≥ 3 months with evidence of kidney damage) is generally not reversible — lost nephrons do not regenerate. However, two important distinctions: (1) Acute kidney injury (AKI) — a sudden drop in kidney function from dehydration, contrast dye, NSAIDs, or sepsis — can fully recover if the cause is removed promptly. Many seniors labeled as having CKD actually had AKI superimposed on aging kidneys. (2) CKD progression can be dramatically slowed with optimal management. SGLT-2 inhibitors, ACE/ARB therapy, blood pressure control (< 130/80), blood sugar control, protein restriction, smoking cessation, and NSAID avoidance can slow CKD progression by 30–50% and delay ESRD by years to decades. 'Slowing progression' is a realistic and important goal even when reversal is not.

Yes. ESRD (end-stage renal disease) is the only diagnosis besides ALS that automatically qualifies a person for Medicare regardless of age. The Medicare ESRD benefit (established 1972) covers: hemodialysis or peritoneal dialysis at a certified facility or at home, dialysis supplies and equipment, home dialysis training, physician fees related to dialysis, some transplant-related costs, and certain anti-rejection medications. Coverage begins: 3 months after dialysis starts for in-center hemodialysis; the month dialysis begins for home dialysis (assuming home dialysis training starts immediately). Patient cost: typically 20% coinsurance for dialysis services (or Part D for oral medications). Medigap supplements can cover this 20%. Home dialysis (peritoneal or home HD) often saves Medicare money vs in-center — Medicare actively supports home dialysis transition through the ESRD Treatment Choices (ETC) Model.

There is no universally 'better' modality — both have comparable survival outcomes in most patients. For elderly seniors specifically, peritoneal dialysis (PD) often has advantages: no needles (catheter is external and tunneled), no required transportation to a center 3 times weekly, gentler fluid removal that is better tolerated by seniors with heart failure, more flexible diet (continuous clearance vs. intermittent), and the ability to perform exchanges during sleep (automated PD). However, PD requires cognitive ability and dexterity (or a trained caregiver) to perform exchanges, abdominal integrity (no significant prior abdominal surgery in some cases), and ability to manage a home clean-technique environment. In-center hemodialysis is appropriate when cognitive impairment or frailty makes home dialysis unsafe, social support is limited, or the patient prefers the supervised setting. Many nephrologists recommend choosing based on lifestyle fit, not medical preference.

Yes — hypertension is the second leading cause of CKD (after diabetes), responsible for approximately 25% of all ESRD cases in the US. Chronically elevated blood pressure damages the glomerular capillaries (the kidney's filtering units), causing progressive scarring (hypertensive nephrosclerosis). As CKD develops, the kidneys lose their ability to regulate blood pressure — worsening hypertension and creating a vicious cycle. Treatment: ACE inhibitors and ARBs (e.g., lisinopril, losartan) are the preferred antihypertensives in CKD because they reduce intra-glomerular pressure beyond their BP-lowering effect, reducing proteinuria (a marker of kidney damage) and slowing CKD progression. SGLT-2 inhibitors (dapagliflozin, empagliflozin) now have Level 1 evidence for kidney protection in CKD regardless of diabetes status. BP target in CKD: < 130/80 mmHg per KDIGO 2021 guidelines, consistent with ACC/AHA hypertension guidelines.

Yes, for most CKD stages. Seniors with CKD G1–G4 can typically live in assisted living — the main benefits are medication management (ensuring ACE/ARB, SGLT-2 inhibitors, and phosphate binders are taken correctly), dietary management (AL dining staff who can accommodate sodium, phosphorus, and potassium restrictions), and monitoring (blood pressure tracking, fluid balance in edematous patients). For CKD G5 requiring dialysis: in-center hemodialysis requires transportation to a dialysis center 3 times weekly — many assisted living communities can arrange transportation, and some communities are specifically designed to accommodate dialysis patients. Home peritoneal dialysis requires a clean space, adequate storage for dialysis supplies, and caregiver assistance or training — feasible in AL with supportive staff. SNF (skilled nursing) is often more appropriate for ESRD patients starting dialysis, for acute CKD complications, or for very frail patients requiring intensive nursing support.